rs10936599 — TERC Near gene (3q26.2)
Near-TERC regulatory variant where the minor T allele associates with shorter telomeres and accelerated cellular aging, while the major C allele produces longer telomeres but paradoxically increases risk for certain cancers
Details
- Gene
- TERC
- Chromosome
- 3
- Risk allele
- T
- Consequence
- Regulatory
- Inheritance
- Additive
- Clinical
- Risk Factor
- Evidence
- Established
- Chip coverage
- v3 v4 v5
Population Frequency
Ancestry Frequencies
Related SNPs
Category
Longevity & AgingSee your personal result for TERC
Upload your DNA data to find out which genotype you carry and what it means for you.
Upload your DNA dataWorks with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.
TERC rs10936599 — The Telomere Length Paradox at 3q26
Telomeres — the repetitive DNA caps that protect chromosome ends — shorten with every cell division, acting as a biological clock that marks cellular age. The gene TERC encodes the RNA template that the telomerase enzyme uses to rebuild these caps, and the chromosomal region 3q26.2 harboring TERC contains some of the strongest genetic determinants of telomere length discovered through population genetics.
rs10936599 is a regulatory variant near TERC that emerged as the single most significant predictor of leukocyte telomere length in the landmark 2013 genome-wide meta-analysis by Codd and colleagues. Its biology illustrates a striking paradox at the heart of telomere science: the allele that maintains longer telomeres also increases the risk of certain cancers, while the allele linked to shorter telomeres — and accelerated cellular aging — appears to reduce cancer susceptibility.
The Mechanism
rs10936599 sits approximately near the 5'UTR region of TERC in an area that influences how much TERC RNA the cell produces or how stable that RNA is. TERC does not encode a protein — it is the RNA template that TERT (the protein catalytic component) uses to add the TTAGGG repeat sequence back to shortening telomere ends.
The C allele (major, ~75% frequency) is associated with higher TERC mRNA levels and
longer telomeres — approximately 117 base pairs more per allele11 117 base pairs more per allele
from the ENGAGE consortium
data in Codd et al. 2013. The T allele (minor,
~25% frequency) appears to reduce TERC expression or activity, resulting in less efficient
telomere rebuilding and telomeres that are measurably shorter over a lifetime.
The paradox arises because longer telomeres suppress cellular senescence — the process that normally kills precancerous cells before they can proliferate. Cells with genetically longer telomeres can divide more times before entering senescence, which is protective against age-related organ failure but removes one of the body's natural cancer checkpoints. This is why the C allele (longer telomere) appears in GWAS findings for colorectal cancer, glioma, lung cancer, and multiple sclerosis susceptibility, while the T allele (shorter telomere) increases risk for cardiovascular disease and COPD — diseases driven by premature cellular exhaustion rather than unchecked proliferation.
The Evidence
The definitive characterization of rs10936599 came from a
genome-wide meta-analysis of 37,684 individuals with replication in 10,739 more22 genome-wide meta-analysis of 37,684 individuals with replication in 10,739 more
Codd V
et al. Identification of seven loci affecting mean telomere length. Nat Genet 2013.
The T allele was the strongest single-SNP predictor of shorter telomeres in the entire
genome (beta = −0.097, P = 2.54×10⁻³¹), explaining 0.36% of variance in leukocyte telomere
length — equivalent to approximately 3.9 years of age-related telomere attrition per T allele.
The same meta-analysis identified rs10936599 as part of a seven-SNP genetic risk score (GRS) for telomere length — a tool now widely used in Mendelian randomization studies to tease apart the causal effects of telomere length from confounders. rs10936599 contributes the largest single weight in this GRS, making it the anchor SNP for genetically determined telomere length in population genetics research.
The earlier
2010 GWAS in 12,409 individuals33 2010 GWAS in 12,409 individuals
Codd V et al. Common variants near TERC are associated
with mean telomere length. Nat Genet 2010
first established the TERC 3q26 locus as the top genetic determinant of leukocyte telomere
length, and rs10936599 tags the strongest signal within this locus.
For cardiovascular health, a
prospective study of acute heart failure patients44 prospective study of acute heart failure patients
Chen et al. Frontiers in Endocrinology
2021 found that rs10936599 genotype was an
independent predictor of 18-month mortality. In the dominant model (CC+CT vs TT), mutant
allele carriers had HR 2.84 (95% CI 1.48–5.44, P = 0.001) for death — a clinically
significant prognostic effect in patients with established heart disease.
A
case-control study in Chinese Han individuals55 case-control study in Chinese Han individuals
Li et al. Scientific Reports 2017
found that the C allele at rs10936599 was associated with increased ischemic stroke risk
(OR = 1.26, 95% CI 1.00–1.58, P = 0.049). This finding, where the longer-telomere C allele
increases stroke risk, reflects the complex pleiotropic effects of telomere length on
vascular biology that vary by context, age, and disease stage.
The Longevity-Aging Framing
In the longevity-aging context, the T allele is the primary concern: it reduces telomere maintenance capacity, accelerating the rate at which cells accumulate telomere damage and enter senescence. Each T allele is equivalent to approximately 3.9 years of extra biological aging at the telomere level. TT homozygotes — carrying two T alleles — have telomeres genetically comparable to someone nearly 8 years older.
Critically, the T allele interacts with lifestyle factors that independently shorten telomeres: smoking, chronic inflammation, psychological stress, and oxidative load. For carriers of the T allele, these environmental insults deplete an already smaller telomere reserve.
The C allele (normal for longevity purposes) does carry its own complex biology — the longer-telomere state mildly increases risk for some cancers by reducing cellular senescence as a tumor-suppressive mechanism. This is worth knowing but is a very different clinical concern from accelerated aging.
Interactions
rs10936599 is part of the TERC 3q26.2 locus that also harbors rs12696304 and rs16847897, two other variants associated with telomere length. These SNPs are not in tight linkage disequilibrium and may tag partially independent regulatory effects on TERC expression. Individuals carrying the T allele at rs10936599 alongside risk alleles at rs12696304 (G) or rs16847897 (C) may have compounded reduction in telomere maintenance from the TERC locus.
At the pathway level, rs10936599 interacts with TERT rs2736100 (the catalytic protein component of telomerase). Both TERC and TERT must function adequately for telomere maintenance; individuals with reduced function at both loci face the most pronounced telomere attrition.
rs10936599 is included in the standard seven-SNP Mendelian randomization genetic instrument for telomere length alongside rs2736100, rs7675998, rs9420907, rs8105767, rs755017, and rs11125529 — reflecting its role as the dominant genetic determinant of leukocyte telomere length in the genome.
Genotype Interpretations
What each possible genotype means for this variant:
Two copies of the common allele associated with longer telomeres and standard cellular aging trajectory
You carry two copies of the C allele at rs10936599, the genotype associated with the longest telomere length at this locus. The C allele is linked to higher TERC expression, greater telomerase activity, and telomeres that maintain their length more effectively across cell divisions. This is the most common genotype globally, present in approximately 56% of people by Hardy-Weinberg frequency from the ~75% C allele frequency.
From a cellular aging standpoint, the CC genotype is favorable — your telomere maintenance capacity at this locus is at the higher end of normal variation, and you are not at genetically elevated risk for telomere-driven accelerated aging from this variant.
The C allele does carry a mild, context-dependent association with slightly higher risk for certain cancers (colorectal, glioma) due to reduced cellular senescence, and may contribute to ischemic stroke susceptibility in some populations. These effects are small and operate through the same long-telomere biology that protects against aging.
One short-telomere allele with mild reduction in TERC-mediated maintenance — roughly equivalent to 3–4 years of additional cellular aging
The primary practical concern for CT carriers is avoiding additional insults to telomere integrity that compound the genetically reduced starting point. Telomere shortening is accelerated by oxidative stress, chronic inflammation, tobacco smoke, and psychological stress — all of which damage the guanine-rich TTAGGG repeat sequence and suppress telomerase activity. With modestly reduced TERC expression from the T allele, the enzyme has slightly less capacity to compensate for this environmental damage.
The CT genotype is sufficient to place rs10936599 in the shorter-telomere tier of Mendelian randomization genetic risk scores used to assess genetically determined telomere length in cardiovascular and aging research.
Two copies of the shorter-telomere allele — genetically equivalent to approximately 7–8 years of additional cellular aging at the TERC locus
The biological consequence of the TT genotype is a chronically reduced TERC RNA template supply for telomerase throughout life. With each cell division, telomerase must rebuild telomere ends using TERC as the sequence template — less TERC means fewer successful extension events and faster net shortening. Over decades of cell turnover in rapidly dividing tissues (blood, gut epithelium, skin), the cumulative deficit becomes measurable in population studies.
Shorter genetically-determined telomeres, as captured by this SNP and the broader genetic risk score, have been causally linked in Mendelian randomization studies to higher risk of cardiovascular disease, coronary heart disease, and earlier onset of age-related conditions. The acute heart failure study (PMID 33763035) showed that rs10936599 genotype independently predicted 18-month mortality with HR 2.84 in the dominant model — suggesting the telomere biology at this locus has clinically relevant prognostic significance in cardiovascular disease settings.
Importantly, the TT genotype interacts with every modifiable factor that independently shortens telomeres. Smoking, chronic systemic inflammation, high oxidative stress, and untreated depression each add to the telomere deficit from two T alleles. The combined burden can be substantial.
Key References
Codd et al. 2013 Nature Genetics — genome-wide meta-analysis in 37,684 individuals identifying rs10936599 T allele as the strongest single predictor of shorter telomere length (beta = −0.097, P = 2.54×10⁻³¹), explaining 0.36% of variance, equivalent to ~3.9 years of age-related telomere attrition per allele
Codd et al. 2010 Nature Genetics — initial GWAS in 12,409 individuals identifying common variants near TERC at 3q26 as the top signal for leukocyte telomere length, establishing the locus that contains rs10936599
Jones et al. 2012 Gut — TERC polymorphisms associated with longer telomeres and colorectal cancer susceptibility; the C allele (longer-telomere allele) increased colorectal cancer and adenoma risk through elevated TERC mRNA and reduced cellular senescence
Li et al. 2017 Scientific Reports — rs10936599 C allele associated with increased ischemic stroke risk in Chinese Han population (OR = 1.26, P = 0.049), adding to the cardiovascular disease associations at this locus
Chen et al. 2021 Frontiers in Endocrinology — rs10936599 mutant alleles (C, framed as the shorter-telomere allele in this cardiac cohort) independently predicted 18-month mortality in acute heart failure (HR 2.84 for CC+TC vs TT in dominant model, P = 0.001)